`
`Novartis Pharma AG
`Postfach
`4002 Basel
`
`@novartis.com
`www.novartis.com
`
`May 1, 2013
`
`D e a r -
`
`Re: Novartis lucentis® Pre-Filled Syringe Program
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00008409
`
`Novartis Exhibit 2124.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`
`
`
`
`
`
`